Bongiovanni M - Search Results

1

Hepatitis B vaccination in HIV-infected subjects.

Bongiovanni M, Casana M. Bongiovanni M, et al. Curr Mol Pharmacol. 2008 Nov;1(3):191-4. doi: 10.2174/1874467210801030191. Curr Mol Pharmacol. 2008. PMID: 20021433 Review.

2

Avascular necrosis of the femoral head in a HIV-1 infected patient receiving lopinavir/ritonavir.

Bongiovanni M, Chiesa E, Riva A, d'Arminio Monforte A, Bini T. Bongiovanni M, et al. Int J Antimicrob Agents. 2003 Dec;22(6):630-1. doi: 10.1016/j.ijantimicag.2003.05.006. Int J Antimicrob Agents. 2003. PMID: 14659664

3

Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir.

Cicconi P, Bongiovanni M, Melzi S, Tordato F, d'Arminio Monforte A, Bini T. Cicconi P, et al. Among authors: bongiovanni m. Int J Antimicrob Agents. 2004 Sep;24(3):284-5. doi: 10.1016/j.ijantimicag.2004.04.005. Int J Antimicrob Agents. 2004. PMID: 15325433

4

Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.

Meraviglia P, Schiavini M, Castagna A, Viganò P, Bini T, Landonio S, Danise A, Moioli MC, Angeli E, Bongiovanni M, Hasson H, Duca P, Cargnel A. Meraviglia P, et al. Among authors: bongiovanni m. HIV Med. 2004 Sep;5(5):334-43. doi: 10.1111/j.1468-1293.2004.00232.x. HIV Med. 2004. PMID: 15369508 Free article.

5

Cutaneous B-cells non-Hodgkin's lymphoma in a HIV-infected female.

Bongiovanni M, Cappelletti A, D'Arminio Monforte A, Bini T. Bongiovanni M, et al. Scand J Infect Dis. 2005;37(1):78-80. doi: 10.1080/00365540410021207. Scand J Infect Dis. 2005. PMID: 15764197 No abstract available.

6

Use of lopinavir/ritonavir in HIV-infected patients failing a first-line protease-inhibitor-containing HAART.

Bongiovanni M, Chiesa E, Di Biagio A, Meraviglia P, Capetti A, Tordato F, Cicconi P, Biasi P, Bini T, d'Arminio Monforte A. Bongiovanni M, et al. J Antimicrob Chemother. 2005 Jun;55(6):1003-7. doi: 10.1093/jac/dki113. Epub 2005 Apr 11. J Antimicrob Chemother. 2005. PMID: 15824089

7

Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals.

Bongiovanni M, Cicconi P, Landonio S, Meraviglia P, Testa L, Di Biagio A, Chiesa E, Tordato F, Bini T, Monforte Ad. Bongiovanni M, et al. Int J Antimicrob Agents. 2005 Jul;26(1):88-91. doi: 10.1016/j.ijantimicag.2005.03.003. Int J Antimicrob Agents. 2005. PMID: 15878262

8

Predictive factors of hyperlipidemia in HIV-infected subjects receiving lopinavir/ritonavir.

Bongiovanni M, Bini T, Cicconi P, Landonio S, Meraviglia P, Testa L, Di Biagio A, Chiesa E, Tordato F, Biasi P, Adorni F, Monforte AD. Bongiovanni M, et al. AIDS Res Hum Retroviruses. 2006 Feb;22(2):132-8. doi: 10.1089/aid.2006.22.132. AIDS Res Hum Retroviruses. 2006. PMID: 16478394

9

Treatment interruptions in HIV-infected subjects.

Bongiovanni M, Casana M, Tincati C, d'Arminio Monforte A. Bongiovanni M, et al. J Antimicrob Chemother. 2006 Sep;58(3):502-5. doi: 10.1093/jac/dkl268. Epub 2006 Jul 1. J Antimicrob Chemother. 2006. PMID: 16816398

10

Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management.

Bongiovanni M, Tincati C. Bongiovanni M, et al. Curr Mol Med. 2006 Jun;6(4):395-400. doi: 10.2174/156652406777435435. Curr Mol Med. 2006. PMID: 16900662 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters